Your browser doesn't support javascript.
loading
Clinical characteristics and outcomes of tyrosine kinase inhibitor-related lower GI adverse effects.
Liu, Cynthia; Amin, Rajan; Shatila, Malek; Short, Nicholas; Altan, Mehmet; Shah, Amishi; Alhalabi, Omar; Okhuysen, Pablo; Thomas, Anusha S; Wang, Yinghong.
Afiliação
  • Liu C; Department of Internal Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Amin R; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Shatila M; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Short N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Altan M; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shah A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Alhalabi O; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Okhuysen P; Department of Infectious Disease, Infection Control and Employment Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Thomas AS; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang Y; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ywang59@mdanderson.org.
J Cancer Res Clin Oncol ; 149(7): 3965-3976, 2023 Jul.
Article em En | MEDLINE | ID: mdl-36030431

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos